The Relationship Between Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Psoriasis Curative Effect Treated with Apremilast: A Retrospective Analysis

In this study, the changes of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in patients with psoriasis were retrospectively analyzed based on the treatment of apremilast. By screening patients with psoriasis before and after treatment with apremilast, relevant blood routine indicators were collected, and NLR and PLR were calculated. The results showed that both NLR and PLR were significantly reduced after treatment with apremilast. This suggests that the inflammatory response is improved in patients with psoriasis and that apremilast may have an inhibitory effect on white blood cell platelet activation. These results suggest that NLR and PLR may be useful indicators to evaluate the condition of psoriasis and the therapeutic effect of apremilast. This provides a new reference index and treatment strategy for the clinic and has positive practical guiding significance for the prevention and treatment of psoriasis.